Cases & Deals

GRA Venture Fund invests in Clearside Biomedical

Clients GRA Venture Fund, LLC

Jones Day represented GRA Venture Fund, LLC in connection with its purchase of Series A Convertible Preferred Stock in a private placement by Clearside Biomedical, Inc., an ophthalmic company specializing in the research, development, and commercialization of therapeutic products through a proprietary ocular microinjection platform that targets the individual compartments of the eye.